Qualigen Therapeutics, Inc. Common Stock (QLGN) Revenue (2020 - 2025)
Qualigen Therapeutics, Inc. Common Stock (QLGN) revenue from Jun 30, 2020 to Sep 30, 2025. The TTM Qualigen Therapeutics, Inc. Common Stock (QLGN) revenue is $0. You can adjust inflation or export chart.
Annual Revenue
Quarterly Revenue
Annual Revenue change of Qualigen Therapeutics, Inc. Common Stock (QLGN)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $0 | N/A |
| 2024 | $0 | N/A |
| 2023 | $0 | N/A |
| 2022 | $0 | -100.00% |
| 2021 | $5.65M | +224.71% |
| 2020 | $1.74M | N/A |